Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

Creative Commons License

Hassan M. M., Botrus G., Abdel-Wahab R., Wolff R. A., Li D., Tweardy D., ...More

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol.15, no.11, pp.1791-1799, 2017 (SCI-Expanded) identifier identifier identifier


BACKGROUND & AIMS: Environmental factors have been identified that affect risk of hepatocellular carcinoma (HCC), but little is known about the effects of sex hormones on liver cancer development or outcome. The authors investigated whether menopause hormone therapy (MHT) affects risk, age at onset, or outcome of HCC.